Cargando…
Pitavastatin Is a Highly Potent Inhibitor of T-Cell Proliferation
Repositioning of approved drugs is an alternative time- and cost-saving strategy to classical drug development. Statins are 3-hydroxy-3-methylglutaryl-CoA (HMG CoA) reductase inhibitors that are usually used as cholesterol-lowering medication, and they also exhibit anti-inflammatory effects. In the...
Autores principales: | Voss, Linda, Guttek, Karina, Reddig, Annika, Reinhold, Annegret, Voss, Martin, Simeoni, Luca, Schraven, Burkhart, Reinhold, Dirk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8399298/ https://www.ncbi.nlm.nih.gov/pubmed/34451823 http://dx.doi.org/10.3390/ph14080727 |
Ejemplares similares
-
Screening of FDA-Approved Drug Library Identifies Adefovir Dipivoxil as Highly Potent Inhibitor of T Cell Proliferation
por: Voss, Linda, et al.
Publicado: (2021) -
Zinc Aspartate Induces IL-16 Secretion and Apoptosis in Human T Cells
por: Reinhold, Dirk, et al.
Publicado: (2021) -
Impact of Different JAK Inhibitors and Methotrexate on Lymphocyte Proliferation and DNA Damage
por: Reddig, Annika, et al.
Publicado: (2021) -
Immune Cell-Type Specific Ablation of Adapter Protein ADAP Differentially Modulates EAE
por: Rudolph, Jochen, et al.
Publicado: (2019) -
Selective targeting of transforming growth factor-beta1 into TCR/CD28 signalling plasma membrane domains silences T cell activation
por: Harder, Thomas, et al.
Publicado: (2014)